SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT
SAB Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -6.28M | -7.08M | -4.78M | 985.86K | -17.58M | 1.97M | -2.94M | 1.41M |
Depreciation & Amortization | 1.55M | 778.3K | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | -714.76K | 909.91K | 781K | 677.44K | 1.65K | 415.04K | 300.15K | 277.22K |
Stock-Based Compensation | 1.24M | 612.95K | 674.13K | 1.05M | 601.43K | 617.45K | 536.88K | 639.25K | 644.82K | 602.78K | 628.54K | 578.2K | 569.86K | 897.6K | 2.31K | 880.66K | 433.43K | 349.12K |
Other Working Capital | 783.24K | 346.78K | -2.52M | 1.83M | 115.14K | -2.82M | -321.63K | -1.27M | -44.42K | 1.65M | 6.77M | 987.48K | -2.1M | -1.74M | 13.29M | -3.76M | -613.54K | 2.94M |
Other Non-Cash Items | 2.22M | -5.06M | 2.29M | -54.53K | -2.34M | -5.72M | 10.89M | -195.47K | 50K | 10.94K | 13.86M | -784.48K | -1.73M | -7.86M | 8.59M | -1.84M | -1.5K | -665.6K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.53M | n/a | 357.52K | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a |
Change in Working Capital | 942.8K | 1.06M | -1.88M | 2.1M | 263.34K | -2.77M | -427.41K | -1.49M | 37.13K | 4.21M | 20.3M | -1.8M | 707.17K | -4.99M | 13.3M | -3.76M | -4.18M | 8.08M |
Operating Cash Flow | -7.15M | -7.8M | -9.53M | -6.29M | -7.79M | -10.92M | -13.45M | -5.17M | -4.9M | -1.61M | 27.43M | -8.17M | -4.45M | -10.29M | 4.31M | -3.62M | -6.39M | 9.45M |
Capital Expenditures | n/a | -3 | -55.38K | -100.3K | -52.51K | -129.07K | -67.86K | -85.31K | -22.68K | -21.3K | -8.89M | -78.5K | -612.83K | -1.36M | 5.35M | -3.23M | -3.46M | -1.89M |
Cash Acquisitions | n/a | 500.00 | n/a | n/a | n/a | n/a | n/a | 44.45K | n/a | n/a | n/a | n/a | n/a | 76.39K | n/a | n/a | n/a | n/a |
Purchase of Investments | -122.92K | -70.91K | -1.31M | -4.8M | -105.01K | -31.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.15M |
Sales Maturities Of Investments | 9.99M | 4.74M | 10.69M | 3.75M | 11.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -4.67M | n/a | -337.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -76.39K | n/a | n/a | 76.39K | 99.85M | -110.8M | n/a | n/a |
Investing Cash Flow | 5.2M | 4.67M | 9.33M | -1.15M | 11.22M | -31.36M | -67.86K | -40.86K | -22.68K | -21.3K | -8.97M | -78.5K | -612.83K | -1.28M | 105.21M | -110.8M | -3.46M | -1.89M |
Debt Repayment | -173.84K | -171.91K | 1.15M | -649.13K | -252.33K | -247.44K | 477.76K | -142.74K | -363.79K | -361.68K | -1.07M | -32.17K | -800.18K | -48.75K | -77.27K | -51.23K | -46.23K | -150K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.52M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -2.07K | -911.52K | -25K | n/a | n/a | n/a | n/a | n/a | 1.89K | n/a | n/a | 69.14K | 7.83K | 34.56M | 117.43M | n/a | 104.53K |
Financial Cash Flow | -173.84K | -173.99K | 216.96K | -674.13K | -252.33K | -227.03K | 67.64M | -140.31K | -363.79K | -359.79K | 39.68M | -32.17K | -731.04K | -5.56M | -83.17M | 117.38M | -46.23K | -45.47K |
Net Cash Flow | 2.94M | -3.26M | -273.21K | -8.07M | 3.21M | -42.53M | 54.14M | -5.35M | -5.29M | -1.99M | 31.21M | -8.28M | -5.79M | -17.14M | 38.88M | -9.56M | -9.9M | 7.52M |
Free Cash Flow | -14.48M | -7.8M | -9.59M | -6.39M | -7.84M | -11.05M | -13.51M | -5.25M | -4.92M | -1.63M | 18.54M | -8.25M | -5.06M | -11.65M | 9.67M | -6.85M | -9.85M | 7.56M |